-
1
-
2
-
3
Por Bartholomew J. Eisfelder, Caner Saygin, Joseph Wynne, Margaret W. Colton, Mariafausta Fischietti, Elspeth M. Beauchamp, Jason X. Cheng, Olatoyosi Odenike, Gail Roboz, Houda Alachkar, Wendy StockObter o texto integral
Publicado no Blood Cancer Journal (2021-03-01)
Artigo -
4
Por Jason X. Cheng, Li Chen, Yuan Li, Adam Cloe, Ming Yue, Jiangbo Wei, Kenneth A. Watanabe, Jamile M. Shammo, John Anastasi, Qingxi J. Shen, Richard A. Larson, Chuan He, Michelle M. Le Beau, James W. VardimanObter o texto integral
Publicado no Nature Communications (2018-03-01)
Artigo -
5
Por Jason X. Cheng, Li Chen, Yuan Li, Adam Cloe, Ming Yue, Jiangbo Wei, Kenneth A. Watanabe, Jamile M. Shammo, John Anastasi, Qingxi J. Shen, Richard A. Larson, Chuan He, Michelle M. Le Beau, James W. VardimanObter o texto integral
Publicado no Nature Communications (2018-06-01)
Artigo -
6
Por Sophia C. Korotev, Jason X. Cheng, Yogameenakshi Haribabu, Joshua Strauss, Salina Dominguez, Ashwin Koppayi, Melody Perpich, Madeline Pies, Luke Moma, Aelin Kim, Hatice Basdag, Courtnee Rodgers, Satyajit Kosuri, Ryunosuke Saiki, Hideki Makishima, Sanjukta Tawde, Shelly Galasinski, Priscilla Kandikatla, Hari Prasanna Subramanian, Kehan Ren, Honghao Bi, Mona Mohammadhosseini, Seishi Ogawa, Peng Ji, Anupriya Agarwal, Soma Das, Lucy A. GodleyObter o texto integral
Publicado no Haematologica (2025-02-01)
Artigo -
7
Por Ethan J. Harris, Diren Arda Karaoglu, Madina Sukhanova, Yasmin Abaza, Theodoros Karantanos, Ann-Kathrin Eisfeld, Clare Anderson, Chenyu Lin, Yenny A. Moreno Vanegas, Talha Badar, Alexander Coltoff, Todd C. Knepper, Neval Ozkaya, Hamed Rahmani Youshanlouei, Sinan Cetin, Anand A. Patel, Adam S. DuVall, Michael W. Drazer, Peng Wang, Melissa Tjota, Jeremy P. Segal, Girish Venkataraman, Sandeep Gurbuxani, Jason X. Cheng, Daniel A. Arber, Richard A. Larson, Olatoyosi Odenike, Jonathan Webster, Bijal Shah, Wendy Stock, Caner SayginObter o texto integral
Publicado no Blood Cancer Journal (2025-08-01)
Artigo -
8
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasmsPor Amandeep Kaur, Alexandra E. Rojek, Emily Symes, Mariam T. Nawas, Anand A. Patel, Jay L. Patel, Payal Sojitra, Barina Aqil, Madina Sukhanova, Megan E. McNerney, Leo P. Wu, Aibek Akmatbekov, Jeremy Segal, Melissa Y. Tjota, Sandeep Gurbuxani, Jason X. Cheng, Su-Yeon Yeon, Harini V. Ravisankar, Carrie Fitzpatrick, Angela Lager, Michael W. Drazer, Caner Saygin, Pankhuri Wanjari, Panagiotis Katsonis, Olivier Lichtarge, Jane E. Churpek, Sharmila B. Ghosh, Ami B. Patel, Madhu P. Menon, Daniel A. Arber, Peng Wang, Girish VenkataramanObter o texto integral
Publicado no Blood Cancer Journal (2024-06-01)
Artigo